Severe toxicity-free survival following acute lymphoblastic leukemia in patients aged 1-45 years: a Danish cohort study.
This study evaluated long-term, severe treatment-related toxicities in a nationwide cohort of 506 patients aged 1–45 y...
Intranasal fentanyl and impact of an emergency department pain protocol for sickle cell disease on hospitalization rates.
- Post category:Hematologic Cancers
- Reading time:1 min read
The study examined a standardized, nurse-initiated emergency department pain protocol for children and young adults with...
Two Drugs, One Stunning Myeloma Result.
- Post category:Hematologic Cancers
- Reading time:1 min read
This report describes a clinical study in relapsed multiple myeloma where a BCMA-directed T‑cell engager was combined...
New BTK Inhibitors May Combat Resistance in CLL.
- Post category:Hematologic Cancers
- Reading time:2 mins read
The publication highlights emerging data on next‑generation, noncovalent BTK inhibitors in chronic lymphocytic leukemi...
In Vivo CAR T Cells Deliver Deep Responses in Myeloma.
- Post category:Hematologic Cancers
- Reading time:1 min read
This report describes early clinical results of an in vivo CAR T-cell approach for relapsed multiple myeloma, in which p...
Immune thrombocytopenia: contemporary pathophysiology, treatment gaps, and the role of novel mechanisms in patient-centered care.
- Post category:Hematologic Cancers
- Reading time:2 mins read
This publication reviews the evolving pathophysiologic understanding and targeted management of immune thrombocytopenia...